Chemomab Therapeutics (CMMB) vs Vistagen Therapeutics (VTGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Chemomab Therapeutics (CMMB) has outperformed Vistagen Therapeutics (VTGN) over the past year, losing 60.7% versus a loss of 93.8%. Over five years, CMMB leads with a -96.2% price change compared with -99.7% for VTGN. Vistagen Therapeutics is the larger company by market cap ($10.7 million vs $10.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CMMB | VTGN |
|---|---|---|
| Share price | $1.38 | $0.2417 |
| Market cap | $10.09M | $10.73M |
| 1-day change | +1.27% | -2.19% |
| YTD return | -16.97% | -62.56% |
| 1-year return | -60.69% | -93.76% |
| 5-year return | -96.23% | -99.66% |
| EPS (TTM) | $-1.04 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.55 | $5.14 |
| 52-week low | $1.05 | $0.20 |
| Distance from 52-week high | -61.20% | -95.30% |
| Average volume | 118.53K | 12.38M |
| Shares outstanding | 7.33M | 44.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CMMB has outperformed VTGN by 33.1 percentage points over the past year.
CMMB vs VTGN FAQ
Which is bigger, Chemomab Therapeutics or Vistagen Therapeutics?
Vistagen Therapeutics (VTGN) is larger, with a market capitalization of $10.73M compared with $10.09M for Chemomab Therapeutics (CMMB).
Which stock has performed better over the past year, CMMB or VTGN?
CMMB returned -60.69% over the past 12 months, compared with -93.76% for VTGN (price return, excluding dividends). Past performance does not predict future results.
Are Chemomab Therapeutics and Vistagen Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.